Patent ID: 6124338
Filing Date: 2000-09-26
Classification: A61K,A61P

Abstract:
A method for treating a patient having a medical condition for which a 5-HT.sub.1D -like receptor agonist is indicated, said medical condition being selected from the group consisting of migraine, and cluster headache; wherein said method comprises the step of administering to the patient an effective amount of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and, in an amount effective to stimulate a 5-HT.sub.1D -like receptor, a compound according to Formula II: ##STR8## wherein R.sup.1 is selected from H, C.sub.1-6 alkyl and benzyl;R.sup.2 is selected from H and C.sub.1-6 alkyl;R.sup.3 is selected from H and C.sub.1-6 alkyl;R.sup.4 is selected from C.sub.1-6 alkyl and halo;R.sup.5 is selected from H and OH;or a pharmaceutically acceptable salt or hydrate thereof.